According to Cognitive Market Research, the global Plasma Derived Medicine Market size is USD 31515.2 million in 2024 and will expand at a compound annual growth rate (CAGR) of 7.00% from 2024 to 2031.
North America held the major market of more than 40% of the global revenue with a market size of USD 12606.08 million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.2% from 2024 to 2031.
Europe accounted for a share of over 30% of the global market size of USD 9454.56 million.
Asia Pacific held the market of around 23% of the global revenue with a market size of USD 7248.50 million in 2024 and will grow at a compound annual growth rate (CAGR) of 9.0% from 2024 to 2031.
The Latin American market will account for more than 5% of global revenue and have a market size of USD 1575.76 million in 2024. It will grow at a compound annual growth rate (CAGR) of 6.4% from 2024 to 2031.
The Middle East and Africa held the major markets, accounting for around 2% of the global revenue. The market was USD 630.30 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.7% from 2024 to 2031.
The hospital pharmacies held the highest plasma derived medicine market revenue share in 2024
